1. El-Kaissi S, Frauman AG, Wall JR. Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. Intern Med J. 2004; 34(8):482–91.
Article
2. Wall JR, Bernard N, Boucher A, Salvi M, Zhang ZG, Kennerdell J, et al. Pathogenesis of thyroid-associated ophthalmopathy: an autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis. Clin Immunol Immunopathol. 1993; 68(1):1–8.
Article
3. Tjiang H, Lahooti H, McCorquodale T, Parmar KR, Wall JR. Eye and eyelid abnormalities are common in patients with Hashimoto's thyroiditis. Thyroid. 2010; 20(3):287–90.
Article
4. Kan E, Kan EK, Ecemis G, Colak R. Presence of thyroidassociated ophthalmopathy in Hashimoto's thyroiditis. Int J Ophthalmol. 2014; 7(4):644–7.
5. Kochairi IE, Champion B, Wall JR. Risk factors for the development of ophthalmopathy in patients with Hashimoto's thyroiditis. Ophthalmology Research. 2014; 2(4):177–88.
Article
6. Yoshihara A, Yoshimura Noh J, Nakachi A, Ohye H, Sato S, Sekiya K, et al. Severe thyroid-associated orbitopathy in Hashimoto's thyroiditis. Report of 2 cases. Endocr J. 2011; 58(5):343–8.
Article
7. Tateno F, Sakakibara R, Kishi M, Ogawa E. Hashimoto's ophthalmopathy. Am J Med Sci. 2011; 342(1):83–5.
Article
8. Grzesiuk W, Szydlarska D, Pragacz A, Bar-Andziak E. Thyroid-associated orbitopathy in patients with Hashimoto's thyroiditis: a case report. Pol Arch Med Wewn. 2008; 118(5):318–21.
Article
9. Hiraga A, Mimura M, Kamitsukasa I. Isolated inferior rectus muscle myopathy due to Hashimoto's thyroiditis. Intern Med. 2008; 47(13):1283–4.
Article
10. Jacobson DM. Dysthyroid orbitopathy. Semin Neurol. 2000; 20(1):43–54.
Article
11. Garrity JA, Bahn RS. Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment. Am J Ophthalmol. 2006; 142(1):147–53.
Article
12. Costa RM, Dumitrascu OM, Gordon LK. Orbital myositis: diagnosis and management. Curr Allergy Asthma Rep. 2009; 9(4):316–23.
Article
13. Hughes T, Adler A, Merrill JT, Kelly JA, Kaufman KM, Williams A, et al. Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus. Ann Rheum Dis. 2012; 71(5):694–9.
Article
14. Bahn RS. Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab. 2003; 88(5):1939–46.
15. Starkey KJ, Janezic A, Jones G, Jordan N, Baker G, Ludgate M. Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol. 2003; 30(3):369–80.
Article
16. Gopinath B, Ma G, Wall JR. Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis. Thyroid. 2007; 17(11):1123–9.
Article
17. Gopinath B, Musselman R, Adams CL, Tani J, Beard N, Wall JR. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features. Thyroid. 2006; 16(10):967–74.
Article
18. Lahooti H, Parmar KR, Wall JR. Pathogenesis of thyroidassociated ophthalmopathy: does autoimmunity against calse-questrin and collagen XIII play a role? Clin Ophthalmol. 2010; 4:417–25.
19. Wall JR, Lahooti H. Pathogenesis of thyroid eye disease–does autoimmunity against the TSH receptor explain all cases? Endokrynol Pol. 2010; 61(2):222–7.
20. Miller A, Arthurs B, Boucher A, Liberman A, Bernard N, Rodien P, et al. Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity. Thyroid. 1992; 2(3):197–202.
Article